Maxwell Sehested
Impact in
- Oncology top 0.5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
- Toxicology top 0.2%
Papers in
- Oncology 89
- Lung Cancer Research Studies 34
- Neutropenia and Cancer Infections 16
- Cancer Treatment and Pharmacology 14
- Drug Transport and Resistance Mechanisms 13
- Co-authors
- Peter Buhl JensenJiří BártekJiřina BártkováNiels BorregaardClaudia LukasZuzana Hořejšı́Jahn M. NeslandFrederic Tort
- Journals
- Biochemical Pharmacology (11 papers)Cancer Chemotherapy and Pharmacology (10 papers)British Journal of Cancer (10 papers)Molecular Pharmacology (6 papers)Journal of Biological Chemistry (6 papers)
- Partner nations
- DenmarkUnited StatesSingapore
In The Last Decade
Maxwell Sehested
153 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 4.4k
- Toxicology 365
- Molecular Biology 6.7k
- Cancer Research 1.4k
- Geriatrics and Gerontology 232
Countries citing papers authored by Maxwell Sehested
This map shows the geographic impact of Maxwell Sehested's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxwell Sehested with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxwell Sehested more than expected).
Fields of papers citing papers by Maxwell Sehested
This network shows the impact of papers produced by Maxwell Sehested. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxwell Sehested. The network helps show where Maxwell Sehested may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maxwell Sehested, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 32 | |
| 2 | 2009 | 102 | |
| 3 | 2008 | 97 | |
| 4 | 2007 | 65 | |
| 5 | 2006 | 117 | |
| 6 | 2006 | 55 | |
| 7 | SAR analysis of substituted purines as topoisomerase II inhibitors identifies ATPase inhibitors with nanomolar activity. | 2006 | 2 |
| 8 | DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Hit paper breakdown → | 2005 | 2117 |
| 9 | 2005 | 2 | |
| 10 | 2004 | 15 | |
| 11 | 2003 | 308 | |
| 12 | 2003 | 6 | |
| 13 | Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization. | 1997 | 60 |
| 14 | Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer. | 1997 | 85 |
| 15 | 1996 | 357 | |
| 16 | 1993 | 19 | |
| 17 | 1993 | 4 | |
| 18 | 1991 | 6 | |
| 19 | 1990 | 12 | |
| 20 | 1989 | 31 |
About Maxwell Sehested
Maxwell Sehested is a scholar working on Oncology, Toxicology, Molecular Biology, Dermatology and Cancer Research, having authored 154 papers that have together received 9.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (63 papers), Lung Cancer Research Studies (34 papers), Histone Deacetylase Inhibitors Research (16 papers), Neutropenia and Cancer Infections (16 papers), DNA Repair Mechanisms (15 papers), Cancer Treatment and Pharmacology (14 papers), Drug Transport and Resistance Mechanisms (13 papers) and Neuroendocrine Tumor Research Advances (10 papers). The work is most often cited by research in Oncology (4.4k citations), Toxicology (365 citations), Molecular Biology (6.7k citations), Cancer Research (1.4k citations) and Geriatrics and Gerontology (232 citations). Maxwell Sehested has collaborated with scholars based in Denmark, United States and Singapore. Frequent co-authors include Peter Buhl Jensen, Jiří Bártek, Jiřina Bártková, Niels Borregaard, Claudia Lukas, Zuzana Hořejšı́, Jahn M. Nesland, Frederic Tort, Torben F. Ørntoft and Alwin Krämer. Their work appears in journals such as Biochemical Pharmacology, Cancer Chemotherapy and Pharmacology, British Journal of Cancer, Molecular Pharmacology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.